Year |
Citation |
Score |
2018 |
Soler A, Hunter I, Joseph G, Hutcheson R, Hutcheson B, Yang J, Zhang FF, Joshi SR, Bradford C, Gotlinger KH, Maniyar R, Falck JR, Proctor S, Schwartzman ML, Gupte SA, et al. Corrigendum to "Elevated 20-HETE in metabolic syndrome regulates arterial stiffness and systolic hypertension via MMP12 activation" [J. Mol. Cell. Cardiol. 117 (2018) 88-99]. Journal of Molecular and Cellular Cardiology. PMID 29625729 DOI: 10.1016/J.Yjmcc.2018.03.015 |
0.731 |
|
2018 |
Soler A, Hunter I, Joseph G, Hutcheson R, Hutcheson B, Yang J, Zhang FF, Joshi SR, Bradford C, Gotlinger KH, Maniyar R, Falck JR, Proctor S, Schwartzman ML, Gupte SA, et al. Elevated 20-HETE in metabolic syndrome regulates arterial stiffness and systolic hypertension via MMP12 activation. Journal of Molecular and Cellular Cardiology. PMID 29428638 DOI: 10.1016/J.Yjmcc.2018.02.005 |
0.732 |
|
2016 |
Joseph G, Soler A, Hutcheson R, Hunter I, Bradford C, Hutcheson B, Gotlinger KH, Jiang H, Falck JR, Proctor S, Laniado Schwartzman M, Rocic P. Elevated 20-HETE Impairs Coronary Collateral Growth in Metabolic Syndrome Via Endothelial Dysfunction. American Journal of Physiology. Heart and Circulatory Physiology. ajpheart.00561.2016. PMID 28011587 DOI: 10.1152/Ajpheart.00561.2016 |
0.725 |
|
2016 |
Diane A, Pierce WD, Kelly SE, Sokolik S, Borthwick F, Jacome-Sosa M, Mangat R, Pradillo JM, Allan SM, Ruth MR, Field CJ, Hutcheson R, Rocic P, Russell JC, Vine DF, et al. Mechanisms of Comorbidities Associated With the Metabolic Syndrome: Insights from the JCR:LA-cp Corpulent Rat Strain. Frontiers in Nutrition. 3: 44. PMID 27777929 DOI: 10.3389/Fnut.2016.00044 |
0.691 |
|
2015 |
Hutcheson R, Terry R, Hutcheson B, Jadhav R, Chaplin J, Smith E, Barrington R, Proctor SD, Rocic P. miR-21-mediated decreased neutrophil apoptosis is a determinant of impaired coronary collateral growth in metabolic syndrome. American Journal of Physiology. Heart and Circulatory Physiology. 308: H1323-35. PMID 25840830 DOI: 10.1152/Ajpheart.00654.2014 |
0.717 |
|
2014 |
Hutcheson R, Chaplin J, Hutcheson B, Borthwick F, Proctor S, Gebb S, Jadhav R, Smith E, Russell JC, Rocic P. miR-21 normalizes vascular smooth muscle proliferation and improves coronary collateral growth in metabolic syndrome. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 28: 4088-99. PMID 24903275 DOI: 10.1096/Fj.14-251223 |
0.76 |
|
2013 |
Dodd T, Wiggins L, Hutcheson R, Smith E, Musiyenko A, Hysell B, Russell JC, Rocic P. Impaired coronary collateral growth in the metabolic syndrome is in part mediated by matrix metalloproteinase 12-dependent production of endostatin and angiostatin. Arteriosclerosis, Thrombosis, and Vascular Biology. 33: 1339-49. PMID 23599440 DOI: 10.1161/Atvbaha.113.301533 |
0.611 |
|
2013 |
Hutcheson R, Terry R, Chaplin J, Smith E, Musiyenko A, Russell JC, Lincoln T, Rocic P. MicroRNA-145 restores contractile vascular smooth muscle phenotype and coronary collateral growth in the metabolic syndrome. Arteriosclerosis, Thrombosis, and Vascular Biology. 33: 727-36. PMID 23393394 DOI: 10.1161/Atvbaha.112.301116 |
0.721 |
|
2012 |
Hutcheson R, Rocic P. The metabolic syndrome, oxidative stress, environment, and cardiovascular disease: the great exploration. Experimental Diabetes Research. 2012: 271028. PMID 22829804 DOI: 10.1155/2012/271028 |
0.708 |
|
Show low-probability matches. |